Literature DB >> 3186552

Kawasaki disease: cardiac problems and management.

H Kato, O Inoue, T Akagi.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3186552     DOI: 10.1542/pir.9-7-209

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


× No keyword cloud information.
  15 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

Review 2.  Kawasaki disease in the adult: a case report and review of the literature.

Authors:  Juan Carlos Rozo; John L Jefferies; Benjamin W Eidem; Patrick J Cook
Journal:  Tex Heart Inst J       Date:  2004

3.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

4.  Multiple mirror-image peripheral arterial aneurysms in Kawasaki disease.

Authors:  Manraj K S Heran; Aaron Hockley
Journal:  Pediatr Cardiol       Date:  2011-02-17       Impact factor: 1.655

Review 5.  Kawasaki disease: an update.

Authors:  G K Singh
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

Review 6.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

7.  Increased generation of cysteinyl leukotrienes in Kawasaki disease.

Authors:  E Mayatepek; W D Lehmann
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

8.  Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease.

Authors:  E J Tizard; E Baguley; G R Hughes; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

9.  The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B N Chiang
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

10.  Long-term outcome of coronary abnormalities in patients after Kawasaki disease.

Authors:  J Fukushige; N Takahashi; K Ueda; T Hijii; H Igarashi; A Ohshima
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.